SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-000223
Filing Date
2022-01-04
Accepted
2022-01-04 08:08:57
Documents
14
Period of Report
2022-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20220103_8k.htm   iXBRL 8-K 26708
2 EXHIBIT 99.1 ex_321256.htm EX-99.1 13563
  Complete submission text file 0001437749-22-000223.txt   180549

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20220104.xsd EX-101.SCH 3592
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20220104_def.xml EX-101.DEF 11803
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20220104_lab.xml EX-101.LAB 15847
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20220104_pre.xml EX-101.PRE 12018
8 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20220103_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 22504133
SIC: 2834 Pharmaceutical Preparations